Plasma pentraxin 3 is higher in early ovarian hyperstimulation syndrome than in uncomplicated in vitro fertilization cycle of high-risk women

• Published in: Archives of gynecology and obstetrics Vol. 301; no. 6; pp. 1569 - 1578
• Main Authors: Korhonen, Kati, Unkila-Kallio, Leila, Alfthan, Henrik, Hämäläinen, Esa, Tiitinen, Aila, Mikkola, Tomi, Tapanainen, Juha, Savolainen-Peltonen, Hanna
• Format: Journal Article
• Language: English
• Published: Berlin/Heidelberg Springer Berlin Heidelberg 01.06.2020; Springer Nature B.V
• Subjects: Abdomen; Adult; Ascites; C-Reactive Protein - metabolism; Dyspnea; Embryos; Endocrinology; Enzymes; Female; Fertilization in Vitro - methods; Follow-Up Studies; Gynecologic Endocrinology and Reproductive Medicine; Gynecology; Human Genetics; Humans; Immunoassay; In vitro fertilization; Inflammation; Medicine; Medicine & Public Health; Obstetrics; Obstetrics/Perinatology/Midwifery; Ovarian Hyperstimulation Syndrome - blood; Ovarian Hyperstimulation Syndrome - etiology; Patients; Plasma; Pregnancy; Prospective Studies; Proteins; Serum Amyloid P-Component - metabolism; Womens health
• ISSN: 0932-0067; 1432-0711
• DOI: 10.1007/s00404-020-05556-9

Purpose Pentraxin 3 (PTX3) is a locally secreted, quicker responsive pro-inflammatory protein than C-reactive protein (CRP). We evaluated the value of PTX3 in the prediction of ovarian hyperstimulation syndrome (OHSS), a severe complication of in vitro fertilization (IVF). Methods This two-year prospective follow-up study included 27 women with uncomplicated IVF-cycles (IVF group) and 31 patients diagnosed with moderate or severe early OHSS (OHSS group). PTX3 was analysed from follicular fluid (FF) and serial blood samples with enzyme-linked immunoassay and CRP with particle-enhanced immunoturbidimetric assay. The value of PTX3 and CRP in detecting OHSS was examined with receiver operating characteristic (ROC) curve analysis and expressed as the area under the curve (AUC). Results The circulating PTX3 level peaked at two days after oocyte pick-up (OPU2), and in the OHSS group the level was 1.9 times higher ( P  = 0.006) than in the IVF group. However, in ROC curve analysis PTX3 (AUC 0.79, best cut off 1.1 µg/L) was not superior to CRP (AUC 0.87; best cut off 9.5 mg/L) in predicting early OHSS. In the IVF group, the FF-PTX3 concentration was 15–20 times higher than in the plasma. PTX3 level at OPU2 correlated with the number of punctured follicles ( r  = 0.56, n  = 22, P  = 0.006). Triggering with human chorionic gonadotrophin or early pregnancy had no effect on PTX3 level. Conclusion The elevated PTX3 concentration in OHSS at OPU2, when freeze-all embryos strategy is still possible to consider, indicates that PTX3 level could provide additional benefit in the risk assessment for early OHSS.